Repro-Med Systems, Inc. Share Price OTC Bulletin Board
Equities
US7599101026
Medical Equipment, Supplies & Distribution
Sales 2024 * | 31.75M 2.65B | Sales 2025 * | 37.64M 3.14B | Capitalization | 102M 8.48B |
---|---|---|---|---|---|
Net income 2024 * | -7M -584M | Net income 2025 * | -4M -334M | EV / Sales 2024 * | 3.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.7 x |
P/E ratio 2024 * |
-14.1
x | P/E ratio 2025 * |
-26.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.12% |
Latest transcript on Repro-Med Systems, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Linda Tharby
CEO | Chief Executive Officer | 56 | 12/21/12 |
Thomas Adams
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Brent Rutland
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Cascella
BRD | Director/Board Member | 69 | 01/22/01 |
R. Fletcher
CHM | Chairman | 78 | 07/19/07 |
Edward Wholihan
BRD | Director/Board Member | 64 | 28/23/28 |
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |